Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M A Kay

Showing results (101-110 of 110) with videos related to

Pageof 11
Sort By:
You have reached the last page of results.This site can display upto 110 results.
Science (New York, N.Y.)|October 1, 1993
In vivo gene therapy of hemophilia B: sustained partial correction in factor IX-deficient dogsM A Kay, S Rothenberg, C N Landen, et al.
The Journal of Biological Chemistry|September 25, 1999
NF-kappaB activation is required for human endothelial survival during exposure to tumor necrosis factor-alpha but not to interleukin-1beta or lipopolysaccharideK Zen, A Karsan, A Stempien-Otero, et al.
Human Gene Therapy|August 1, 1995
Gene therapy for hemophilia B: host immunosuppression prolongs the therapeutic effect of adenovirus-mediated factor IX expressionB Fang, R C Eisensmith, H Wang, et al.
Nature|November 4, 2014
Promoterless gene targeting without nucleases ameliorates haemophilia B in miceA Barzel, N K Paulk, Y Shi, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|July 1, 2010
Prevention of spontaneous bleeding in dogs with haemophilia A and haemophilia BT C Nichols, R A Raymer, H W G Franck, et al.
Nature Genetics|July 1, 1997
Persistent and therapeutic concentrations of human factor IX in mice after hepatic gene transfer of recombinant AAV vectorsR O Snyder, C H Miao, G A Patijn, et al.
Oncogene|December 10, 2013
Upregulation of the microRNA cluster at the Dlk1-Dio3 locus in lung adenocarcinomaP N Valdmanis, B Roy-Chaudhuri, H K Kim, et al.
Nature Medicine|January 12, 1999
Correction of hemophilia B in canine and murine models using recombinant adeno-associated viral vectorsR O Snyder, C Miao, L Meuse, et al.
Nature Genetics|March 4, 2000
Evidence for gene transfer and expression of factor IX in haemophilia B patients treated with an AAV vectorM A Kay, C S Manno, M V Ragni, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 12, 2001
Lack of germline transmission of vector sequences following systemic administration of recombinant AAV-2 vector in malesV R Arruda, P A Fields, R Milner, et al.
Pageof 11

Showing results (101-110 of 110) with videos related to

Sort By:
Pageof 11
You have reached the last page of results.This site can display upto 110 results.
Science (New York, N.Y.)|October 1, 1993
In vivo gene therapy of hemophilia B: sustained partial correction in factor IX-deficient dogsM A Kay, S Rothenberg, C N Landen, et al.
The Journal of Biological Chemistry|September 25, 1999
NF-kappaB activation is required for human endothelial survival during exposure to tumor necrosis factor-alpha but not to interleukin-1beta or lipopolysaccharideK Zen, A Karsan, A Stempien-Otero, et al.
Human Gene Therapy|August 1, 1995
Gene therapy for hemophilia B: host immunosuppression prolongs the therapeutic effect of adenovirus-mediated factor IX expressionB Fang, R C Eisensmith, H Wang, et al.
Nature|November 4, 2014
Promoterless gene targeting without nucleases ameliorates haemophilia B in miceA Barzel, N K Paulk, Y Shi, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|July 1, 2010
Prevention of spontaneous bleeding in dogs with haemophilia A and haemophilia BT C Nichols, R A Raymer, H W G Franck, et al.
Nature Genetics|July 1, 1997
Persistent and therapeutic concentrations of human factor IX in mice after hepatic gene transfer of recombinant AAV vectorsR O Snyder, C H Miao, G A Patijn, et al.
Oncogene|December 10, 2013
Upregulation of the microRNA cluster at the Dlk1-Dio3 locus in lung adenocarcinomaP N Valdmanis, B Roy-Chaudhuri, H K Kim, et al.
Nature Medicine|January 12, 1999
Correction of hemophilia B in canine and murine models using recombinant adeno-associated viral vectorsR O Snyder, C Miao, L Meuse, et al.
Nature Genetics|March 4, 2000
Evidence for gene transfer and expression of factor IX in haemophilia B patients treated with an AAV vectorM A Kay, C S Manno, M V Ragni, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 12, 2001
Lack of germline transmission of vector sequences following systemic administration of recombinant AAV-2 vector in malesV R Arruda, P A Fields, R Milner, et al.
Pageof 11